Radiation-Dose-Lowering Effect of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography: A Prospective Multicentre Study
Phase of Trial: Phase IV
Latest Information Update: 16 May 2016
Price : $35 *
At a glance
- Drugs Landiolol (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms DELIGHT
- 28 Mar 2016 Status changed from active, no longer recruiting to completed, according to the results published.
- 28 Mar 2016 Primary endpoint has been met, according to the results published.
- 28 Mar 2016 Results (n=219) published in the Circulation Journal.